Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VUDALIMAB for Adenocarcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where VUDALIMAB was used for Adenocarcinoma.

Most Reported Side Effects for VUDALIMAB

Side Effect Reports % Deaths Hosp.
Anaemia 21 31.8% 3 19
C-reactive protein increased 20 30.3% 7 20
Pyrexia 18 27.3% 0 16
Malignant neoplasm progression 13 19.7% 5 11
Pneumonia 13 19.7% 2 13
Dyspnoea 12 18.2% 1 11
Nausea 12 18.2% 6 11
Platelet count decreased 12 18.2% 1 10
Hypoxia 10 15.2% 2 10
Vomiting 10 15.2% 0 10
Abdominal pain 9 13.6% 7 9
Asthenia 9 13.6% 0 8
Fatigue 9 13.6% 1 6
Hypotension 9 13.6% 1 9
Blood creatinine increased 8 12.1% 0 8

Other Indications for VUDALIMAB

Non-small cell lung cancer (37) Prostate cancer (5)

Other Drugs Used for Adenocarcinoma

OXALIPLATIN (646) CARBOPLATIN (581) FLUOROURACIL (548) PACLITAXEL (398) PEMBROLIZUMAB (384) PEMETREXED (374) DOCETAXEL (350) BEVACIZUMAB (338) CAPECITABINE (338) NIVOLUMAB (304)

Related Pages

VUDALIMAB Full Profile All Adenocarcinoma Drugs VUDALIMAB Demographics VUDALIMAB Timeline